Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Equal-Weight on Phillips Edison, Lowers Price Target to $32

Morgan Stanley maintains Phillips Edison (NASDAQ:PECO) with a Equal-Weight and lowers the price target from $37 to $32.

byBenzinga Newsdesk

May 13, 2022

1 minute read

Morgan Stanley maintains Phillips Edison (NASDAQ:PECO) with a Equal-Weight and lowers the price target from $37 to $32.

After FDA Rejection Troubled Biotech Pulls Europe Application For Bladder Cancer Drug

By Vandana Singh

Today, 10:23 PM

Two weeks ago, Sesen Bio Inc (NASDAQ: SESN) was on the cusp of winning FDA approval for the cancer drug Vicineum.

SESN

Processa Pharmaceuticals Provides Update On Enrollment Across All Clinical Programs

By Benzinga Newsdesk

Today, 10:23 PM

PCS12852 for Gastroparesis concluded enrollment a month ahead of schedule. Statistics on gastric emptying, safety and GEBT data will be available by the end of October and full topline data is expected before year

PCSA

NorthWestern Q1 EPS $1.08

By Benzinga Newsdesk

Today, 10:23 PM

NorthWestern (NASDAQ:NWE) reported quarterly earnings of $1.08 per share.

NWE

‘The Bear Market Is Over’: Sundial Research Founder

By AJ Fabino

Today, 10:23 PM

The S&P 500 has experienced 110 reversals in the previous 135 sessions, representing 1% shifts from high or low to close. Recent sessions have seen an extraordinary increase in the volume of buyers who are eager to acquire visibility.

Morgan Stanley Maintains Equal-Weight on Phillips Edison, Lowers Price Target to $32

Related Posts

After FDA Rejection Troubled Biotech Pulls Europe Application For Bladder Cancer Drug

Processa Pharmaceuticals Provides Update On Enrollment Across All Clinical Programs

NorthWestern Q1 EPS $1.08

‘The Bear Market Is Over’: Sundial Research Founder